| |
|
| |
| Stem Cell News |
| |
| |
Overturning stem cell patents will "blow things wide open.
Embryonic stem cell research in Maryland and throughout the nation could benefit from a recent federal regulatory decision to overturn the University of Wisconsin's patents on the science.
Published April 4, 2007/Daily Record
GlobalStem blazes new trails in stem cell research
-- The political and ethical firestorm over embryonic stem cell research might scare more than a few entrepreneurs away from the issue. But for Jonathan M. Auerbach, the debate is part of what makes the field enticing. Auerbach, president and CEO of GlobalStem Inc. in Rockville, founded the company last March to provide himself and his fellow researchers an innovative inroad into the burgeoning area of science.
Published February 8, 2007 /Daily Record/
Advocates urge more stem cell research funds
-- Several states have committed funds, or are considering doing so, to stem cell research, which scientists believe has the potential to find treatments or cures for numerous diseases, including Parkinson’s, juvenile diabetes and Alzheimer’s.
Published 24rd January 2007 /Daily Record/
Stem cell patents loosened
-- WARF lifts some licensing restrictions on industry and academic research, but critics vow to continue challenging the patents.
Published 23rd January 2007 /The Scientist/
Mediatech, Inc. and GlobalStem, Inc. Form Strategic Alliance
-- Mediatech, Inc., makers of the brand cellgro(R), and GlobalStem, Inc. have recently formed a strategic alliance to develop, manufacture, validate, and distribute Embryonic Stem Cell-qualified growth media and supplements. HERNDON, Va., Nov. 7 /PRNewswire/
WARF stem cell patents challenged
Research could get faster and cheaper if the patents are narrowed, some scientists say. Published 10th October 2006 /The Scientist/
|
|
|
| |
|
| |
| |
| Welcome to GlobalStem, Inc |
| |
| Founded in March 2006, GlobalStem boasts a highly experienced, well-trained staff of stem cell experts. We are focused on creating standardized stem cell tools and providing contract services and technical support. Our products and services are tailored for the basic, applied, and clinical research communities. Located in Rockville, Maryland, close to Washington, DC, we are in a fast-paced, stimulating environment populated by world-class research institutions and companies. |
| |
| Stem cells, particularly human embryonic stem cells (hESCs), are a notoriously labile cell type. If the utmost of care is not taken, these cells will spontaneously differentiate in culture and tend to undergo genomic rearrangements. Currently, few commercial products have been developed specifically for human embryonic stem cells. |
|
|
|
| |
|
| |
| |
With years of scientific expertise, we will help researchers maintain and characterize both human and mouse embryonic stem cells by providing ES-qualified growth media, sera, supplements, growth factors, and assay kits. In addition, we will offer in-house custom-based services to ensure the identity and the stability of the stem cell lines. |
|
|
|
| |
| |  | |
| |
|
|
